Drugs / stem cell therapy

Trials 3 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT06132542 Jan → Oct 2024 primary ovarian failure Mongolian National University of Medical Sciences Unknown No outcome recorded
Phase 1 NCT00535548 Jan → Dec 2007 decubitus ulcer University Hospital, Basel, Switzerland Unknown No outcome recorded
Phase 41 trial
Phase 4 NCT05658692 Oct 2022 → Oct 2023 acute respiratory distress syndrome Second Affiliated Hospital, School of Medicine, Zhejiang University Unknown No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00418418 Comparator Oct 2006 → Dec 2009 coronary artery disorder, myocardial infarction, systolic heart failure University of Helsinki Unknown No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as stem cell therapy ClinicalTrials.gov intervention name — accepted as the source's own label NCT06132542
2

NCT05658692

NCT00535548

Known as Intramyocardial mesenchymal stem cell transplantation ClinicalTrials.gov intervention name — accepted as the source's own label NCT00418418
Action Restore “We are planning to investigate the effectiveness of adipose stem cell on ovarian tissue regeneration for patients with premature ovarian failure.” NCT06132542
Modality Cell therapy “mesenchymal stem cell transplantation” NCT00418418
Route Other “stem cells are directly injected to myocardium” NCT00418418